International Prognostic Scoring System for Waldenstrom Macroglobulinemia

Estimate prognosis with the IPPSWM


The IPSSWM was derived after merging a cohort of patients with WM from 7 international co-operative groups. The IPSSWM speicifcially focuse on symptomatic patinets requiring therapy, and the majority were treated with standard therapies including alkylating agents, purine analogs, and rituximab.


Morel P, Duhamel A, Gobbi P, Dimopoulos MA, Dhodapkar MV, McCoy J, Crowley J, Ocio EM, Garcia-Sanz R, Treon SP, Leblond V, Kyle RA, Barlogie B, Merlini G.

Blood. 2009 Apr 30;113(18):4163-70. doi: 10.1182/blood-2008-08-174961. Epub 2009 Feb 5.

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. Age

0/5 completed